Covered recipient · General Payments record
RASHA N BEG
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$14,407.11
- Reported across 655 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,560.00 | 1 |
| Food and Beverage | $1,457.85 | 38 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $1,710.00 | 2 |
| SOBI, INC | $155.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $126.45 | 5 |
| BeiGene USA, Inc. | $122.99 | 1 |
| GlaxoSmithKline, LLC. | $119.28 | 1 |
| E.R. Squibb & Sons, L.L.C. | $113.50 | 1 |
| Janssen Biotech, Inc. | $59.07 | 3 |
| Tempus AI, Inc | $56.48 | 2 |
| Genentech USA, Inc. | $55.88 | 2 |
| Merck Sharp & Dohme Corporation | $51.14 | 2 |
| Karyopharm Therapeutics Inc. | $49.25 | 2 |
| Pharmacosmos Therapeutics Inc. | $47.44 | 2 |
| PFIZER INC. | $45.06 | 2 |
| Celgene Corporation | $43.34 | 2 |
| GENZYME CORPORATION | $38.59 | 1 |
| PharmaEssentia USA Corporation | $27.44 | 1 |
| Sumitomo Pharma America, Inc. | $26.75 | 1 |
| Dendreon Pharmaceuticals LLC | $26.13 | 1 |
| ADC Therapeutics America, Inc. | $25.36 | 1 |
| Coherus Biosciences Inc. | $22.94 | 1 |
| Adaptive Biotechnologies Corporation | $22.60 | 1 |
| MENARINI SILICON BIOSYSTEMS, INC. | $22.15 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $18.85 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.25 | 1 |
| Stemline Therapeutics Inc. | $14.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (39)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.